Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/2000
08/16/2000EP0509080B1 Inhibitors and substrates of thrombin
08/16/2000CN1263560A Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in sample of normal cells
08/16/2000CN1263556A Anti-GPIIB/IIIA recombinant antibodies
08/16/2000CN1263534A A preparation derived from shark cartilage for treatment of diseases related to excessive PHF or excessive intracellular calcium
08/16/2000CN1263528A N-triazolyl-2-indolecarboxamides and their use as CCK-A agonists
08/16/2000CN1263522A Compounds and methods for inhibition of expression of VCAM-1
08/16/2000CN1263473A Composition and method for enhancing transport across biological membranes
08/16/2000CN1263471A Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing antitumor agent and hydroxamic acid derivative
08/16/2000CN1263468A Polyallylamine polymers for treating hypercholesterolemia
08/16/2000CN1263466A Solutions containing azasteroids
08/16/2000CN1263462A Monoesters of probucol for treatment of cardiovascular and inflammatory disease
08/16/2000CN1263461A Pharmaceutical composition
08/16/2000CN1263439A Nutritional composition for subjects under stress
08/16/2000CN1263095A New tricycloacylamide compound, its preparation method and medicinal composition containing them
08/16/2000CN1263087A Substituted alkyl tetramine derivative
08/16/2000CN1055471C Substituted imidazolidines, their preparing process, and intermediates, their pharmaceutical compositions and there use
08/16/2000CN1055468C Alkylaminoindane compounds process for preparing them and pharmaceutical compositions containing them,and use
08/16/2000CN1055397C Health-care medicine spirit for preventing and curing geriatic disease, delayed senility
08/16/2000CN1055390C Process for preparing pharmaceutical composition having synergistic effect
08/16/2000CA2298190A1 Compound for oxidation dying of keratinous fibres and dying process using the said compound
08/15/2000US6103936 Reacting aldehyde, sulfide, sulfone, or sulfoxide with formamide in presence of acid catalyst, and optionally a dehydrating agent
08/15/2000US6103925 Muscle contraction inhibitors; modulator with selectivity for charybdotoxin-sensitive, calcium-dependent potassium channels
08/15/2000US6103910 D-proline derivatives
08/15/2000US6103902 Carbamoylation process
08/15/2000US6103880 Amino acid sequence of mitogenic peptide; angiogenic agents especially for brain structures; wound healing agents for skin; for bone regeneration especially osteoporosis
08/15/2000US6103874 Human KDEL receptor
08/15/2000US6103869 Isolated polypeptide with a mutation at amino acid 464, 465, and/or 467 resulting in dominant negative inhibition of transforming growth factor-beta signaling; therapy and diagnosis of related diseases
08/15/2000US6103766 Substituted or unsubstituted phenylsulfonamide-phenylamine derivatives useful for treating the disorders related to central nervous system
08/15/2000US6103752 Therapeutic heterocyclic compounds
08/15/2000US6103746 Methods and compositions for the protection of mitochondria
08/15/2000US6103742 Administering to said patient a therapeutically effective amount of an insulin sensitivity enhancer in combination with a statin compound to treat diabetes
08/15/2000US6103737 Aryl- and arylamino- substituted heterocycles as corticotropin releasing hormone antagonists
08/15/2000US6103728 Modulating tyrosine signal transduction to prevent and treat cell proliferative disorders or cell differentiation disorders by inhibiting one or more abnormal tyrosine kinase activities; anticarcinogenic,-tumor, proliferative agents
08/15/2000US6103725 High affinity to the dopamine d4 receptor; antagonists; antipsychotic agents, e.g. schizophrenia, with reduced side-effects; antipsychotic agents; anxiolytic and antiemetic agents; motoric functions, addiction, sleep, feeding
08/15/2000US6103722 Ischemic preconditioning
08/15/2000US6103721 Heteroaryl-substituted pyridazino quinoline compounds
08/15/2000US6103720 Ketobenzamides as calpain inhibitors
08/15/2000US6103719 Neurokinin-a- or neurokinin-b tachnkinin antagonistic properties; substance p antagonism; respiratory, gastrointestinal, nervous system, skin disorders;
08/15/2000US6103713 Therapeutic treatment for autoimmune diseases
08/15/2000US6103712 Selective inhibitors of the beta isozyme of protein kinase c inhibits pulmonary vascular permeability, bronchial smooth muscle contractility, and airway hyperactivity, e.g. bisindolylmaleimides
08/15/2000US6103711 Inhibitors of interleukin-1β converting enzyme
08/15/2000US6103513 Novel proteolytic enzyme; for the treatment of immune, proliferative and degratory defects
08/15/2000US6103491 Methods and compositions for identifying morphogen analogs
08/15/2000US6103237 More stable to purification than wild type mature hk2 polypeptide.
08/15/2000US6102254 Pharmaceutical compositions in semisolid form and a device for administration thereof
08/15/2000CA2148671C Stable crystalline (6s)-and (6r)-tetrahydrofolic acid
08/15/2000CA2136553C 7-(2-aminoethyl)-benzothiazolones
08/15/2000CA2046883C Heterocyclic derivatives, method for preparing same, and their therapeutic applications
08/12/2000CA2298156A1 Cosmetic sunscreen compositions based on a synergic combination of filters and uses
08/10/2000WO2000046404A1 Method of diagnosing of exposure to toxic agents by measuring distinct pattern in the levels of expression of specific genes
08/10/2000WO2000046391A2 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
08/10/2000WO2000046389A1 Process for the preparation of pseudomonic acid a antibiotic by microbiological method
08/10/2000WO2000046386A2 Gene repair involving the induction of double-stranded dna cleavage at a chromosomal target site
08/10/2000WO2000046385A1 Gene repair involving in vivo excision of targeting dna
08/10/2000WO2000046376A2 Particles for gene therapy
08/10/2000WO2000046371A1 Tau-conotoxin peptides
08/10/2000WO2000046360A1 Improved helper dependent vector system for gene therapy
08/10/2000WO2000046349A1 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells
08/10/2000WO2000046348A1 Method for inducing differentiation into adipocytes, compound regulating differentiation into adipocytes and method for screening the same
08/10/2000WO2000046249A1 Method for producing il-1ra, a therapeutically active protein from body fluids
08/10/2000WO2000046244A1 cDNA SEQUENCE OF AN INTERACTOR FANCIP1 OF THE FANCONI ANAEMIA PROTEIN OF COMPLEMENTATION GROUP A
08/10/2000WO2000046240A2 Polypeptides involved in immune response
08/10/2000WO2000046228A2 Pyrrolobenzodiazepine carboxyamide vasopressin agonists
08/10/2000WO2000046227A1 Thienylbenzoylbenzazepines as vasopressin agonists
08/10/2000WO2000046225A2 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
08/10/2000WO2000046224A2 Tricyclic pyridine n-oxides vasopressin agonists
08/10/2000WO2000046220A1 Triazole and tetrazole derivatives, and their therapeutic use
08/10/2000WO2000046215A1 Benzazepine derivatives as alpha-v integrin receptor antagonists
08/10/2000WO2000046214A1 Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them
08/10/2000WO2000046209A1 Pyrazolecarboxylic acid derivatives, their preparation, pharmaceutical compositions containing them
08/10/2000WO2000046208A1 Substituted pyrazole carboxylic acids used to combat anaemias
08/10/2000WO2000046204A1 Tetrahydro isoquino linealkanol derivatives and pharmaceutical compositions containing same
08/10/2000WO2000046200A1 2-n-substituted or unsubstituted-2-amino-5-methylpiperidine-3,4-diols and processes for the preparation thereof
08/10/2000WO2000046198A1 Anti-inflammatory indole derivatives
08/10/2000WO2000046196A1 Indole derivatives and their use as mcp-1 antagonists
08/10/2000WO2000046195A1 Anti-inflammatory indole derivatives
08/10/2000WO2000046189A1 Sulfonamide derivatives having cyclic structures
08/10/2000WO2000045851A2 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin
08/10/2000WO2000045849A2 Use of cationic lipids to generate anti-tumor immunity
08/10/2000WO2000045845A2 Liposome composition and method for administration of a radiosensitizer
08/10/2000WO2000045836A1 Uses of thank, a tnf homologue that activates apoptosis
08/10/2000WO2000045818A1 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy
08/10/2000WO2000045817A1 Drug combinations comprising (e) -7 - [4 -(4 -fluorophenyl) -6 - isopropyl -2 - [methyl (methylsulfonyl) amino] pyrimidin -5 -yl] (3r,5s) -3,5 - dihydroxyhept -6 - enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4
08/10/2000WO2000045816A1 Calcilytic compounds
08/10/2000WO2000045791A2 Method for controlling liposome size
08/10/2000WO2000045770A2 Compressed lecithin preparations
08/10/2000WO2000033861A3 Pharmaceutical compositions containing protein-disulfide isomerases
08/10/2000WO2000033824A3 Bioflavonoids, anthocyanins and phenolic compounds from cherries for inhibiting inflammation
08/10/2000WO2000027822A3 Tricyclic pyrazole derivatives
08/10/2000WO2000026399A3 Method for the production of quercetin and isoquercetin derivatives
08/10/2000WO2000024911A3 Human phospholipases
08/10/2000WO2000024773A3 Inhibition of transglutaminase-mediated microbial infection of a mammalian host
08/10/2000WO2000021525A3 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent
08/10/2000WO2000012509B1 Collections of compounds
08/10/2000WO2000010588A9 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs
08/10/2000WO2000010545A3 Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of nk-1 receptor antagonists for the treatment of chronic fatigue syndrome
08/10/2000WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors
08/10/2000DE19904710A1 Substituierte 4-Amino-2-aryl-tetrahydrochinazoline, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation, their use and pharmaceutical compositions containing them
08/10/2000DE19904406A1 Substituierte Pyrazolcarbonsäuren Substituted pyrazole
08/10/2000DE19903876A1 Verfahren zur Induktion von prophylaktisch oder therapeutisch wirksamen Proteinen Method of inducing a prophylactic or therapeutically effective proteins
1 ... 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 ... 1564